L. M. Demers
AuthID: R-006-MBX
1
TITLE: Phase I Trial of Zoledronic Acid plus Imatinib Mesylate (Gleevec) in Patients With Bone Metastases
AUTHORS: Allan Lipton; Cynthia Campbell Baird; Harold Harvey; Christian Kim; Laurence Demers; Luis Costa ;
PUBLISHED: 2010, SOURCE: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, VOLUME: 33, ISSUE: 1
AUTHORS: Allan Lipton; Cynthia Campbell Baird; Harold Harvey; Christian Kim; Laurence Demers; Luis Costa ;
PUBLISHED: 2010, SOURCE: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, VOLUME: 33, ISSUE: 1
2
TITLE: Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis
AUTHORS: Ali, SM; Demers, LM; Leitzel, K; Harvey, HA; Clemens, D; Mallinak, N; Engle, L; Chinchilli, V; Costa, L; Brady, C; Seaman, J; Lipton, A;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15, ISSUE: 3
AUTHORS: Ali, SM; Demers, LM; Leitzel, K; Harvey, HA; Clemens, D; Mallinak, N; Engle, L; Chinchilli, V; Costa, L; Brady, C; Seaman, J; Lipton, A;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15, ISSUE: 3
3
TITLE: Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status
AUTHORS: Costa, L ; Demers, LM; Gouveia Oliveira, A; Schaller, J; Costa, EB; de Moura, MC; Lipton, A;
PUBLISHED: 2002, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 20, ISSUE: 3
AUTHORS: Costa, L ; Demers, LM; Gouveia Oliveira, A; Schaller, J; Costa, EB; de Moura, MC; Lipton, A;
PUBLISHED: 2002, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 20, ISSUE: 3
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef4
TITLE: Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma Full Text
AUTHORS: Costa, LAM; Kopreski, MS; Demers, LM; Chinchilli, VM; Santen, RJ; Harvey, HA; Lipton, A;
PUBLISHED: 1999, SOURCE: CANCER, VOLUME: 85, ISSUE: 1
AUTHORS: Costa, LAM; Kopreski, MS; Demers, LM; Chinchilli, VM; Santen, RJ; Harvey, HA; Lipton, A;
PUBLISHED: 1999, SOURCE: CANCER, VOLUME: 85, ISSUE: 1
5
TITLE: Markers of bone resorption in patients treated with pamidronate Full Text
AUTHORS: Lipton, A; Demers, L; Curley, E; Chinchilli, V; Gaydos, L; Hortobagyi, G; Theriault, R; Clemens, D; Costa, L; Seaman, J; Knight, R;
PUBLISHED: 1998, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 34, ISSUE: 13
AUTHORS: Lipton, A; Demers, L; Curley, E; Chinchilli, V; Gaydos, L; Hortobagyi, G; Theriault, R; Clemens, D; Costa, L; Seaman, J; Knight, R;
PUBLISHED: 1998, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 34, ISSUE: 13
6
TITLE: BIOCHEMICAL MARKERS OF BONE TURNOVER IN PATIENTS WITH METASTATIC BONE-DISEASE
AUTHORS: DEMERS, LM; COSTA, L; CHINCHILLI, VM; GAYDOS, L; CURLEY, E; LIPTON, A;
PUBLISHED: 1995, SOURCE: CLINICAL CHEMISTRY, VOLUME: 41, ISSUE: 10
AUTHORS: DEMERS, LM; COSTA, L; CHINCHILLI, VM; GAYDOS, L; CURLEY, E; LIPTON, A;
PUBLISHED: 1995, SOURCE: CLINICAL CHEMISTRY, VOLUME: 41, ISSUE: 10
INDEXED IN: WOS
WOS